Shandong Huayang Dr Chemical Industry (831304)

Search documents
迪尔化工(831304) - 投资者关系活动记录表
2025-05-13 11:47
证券代码:831304 证券简称:迪尔化工 公告编号:2025-022 山东华阳迪尔化工股份有限公司 投资者关系活动记录表 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 投资者关系活动类别 □特定对象调研 √业绩说明会 □媒体采访 二、 投资者关系活动情况 活动时间:2025 年 5 月 12 日 活动地点:通过"中证网路演平台"(https://rs.cs.com.cn)采用网络远程方 式召开业绩说明会。 参会单位及人员:通过网络方式参加公司 2024 年年度报告业绩说明会的投 资者。 上市公司接待人员:公司董事长:孙立辉先生;公司董事、总经理:高斌先 生;公司董事、副总经理、财务负责人、董事会秘书:卢英华女士;公司保荐代 表人:丁邵楠先生。 三、 投资者关系活动主要内容 问题 1:一季度业绩下跌较大具体原因?如果业绩继续下跌,是否影响 2025 年业绩?对半年报是否有展望? □现场参观 □新闻发布会 □分析师会议 □路演活动 □其他 回复:感谢您的关注和提问,截至目前,年产 20 万吨熔盐储 ...
迪尔化工(831304) - 2024年年度报告业绩说明会预告公告
2025-05-07 10:31
山东华阳迪尔化工股份有限公司 2024 年年度报告业绩说明会预告公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 说明会类型 山东华阳迪尔化工股份有限公司(以下简称"公司")于 2025 年 4 月 21 日 在北京证券交易所信息披露平台(www.bse.cn)披露了《2024 年年度报告》(公 告编号:2025-005),为方便广大投资者更深入了解公司 2024 年年度经营业绩的 具体情况,加强与投资者的互动交流,现定于 2025 年 5 月 12 日召开 2024 年年 度报告业绩说明会。 二、 说明会召开的时间、地点 (一)会议召开时间:2025 年 5 月 12 日(周一)15:00-17:00。 证券代码:831304 证券简称:迪尔化工 公告编号:2025-021 公司董事长:孙立辉先生 公司董事、总经理:高斌先生 公司董事、副总经理、财务负责人、董事会秘书:卢英华女士 公司保荐代表人:丁邵楠先生 四、 投资者参加方式 本次说明会采用网络方式召开。 为充分尊重投资者、提升交流的针对 ...
迪尔化工(831304) - 2024 Q4 - 年度财报
2025-04-21 15:10
Financial Performance - The company's operating revenue for 2024 reached ¥782,457,247.89, representing a 2.71% increase compared to ¥761,794,929.03 in 2023[24] - The net profit attributable to shareholders for 2024 was ¥86,156,206.23, reflecting a 9.31% increase from ¥78,815,053.84 in 2023[24] - The gross profit margin improved to 19.81% in 2024, up from 15.67% in 2023[24] - Total assets increased by 15.78% to ¥767,024,991.09 at the end of 2024, compared to ¥662,506,745.80 at the end of 2023[25] - The company's net assets attributable to shareholders rose by 10.80% to ¥504,312,310.07 in 2024, up from ¥455,147,391.84 in 2023[25] - The cash flow from operating activities decreased by 29.89% to ¥61,085,020.55 in 2024, down from ¥87,128,578.75 in 2023[25] - The weighted average return on equity based on net profit attributable to shareholders was 18.06% in 2024, down from 21.10% in 2023[24] - The company achieved operating revenue of 782,457,247.89 CNY, with a year-on-year growth of 2.71%[40] - The net profit attributable to shareholders reached 86,156,206.23 CNY, reflecting a year-on-year increase of 9.31%[40] - The company reported a basic earnings per share of 0.53 CNY, consistent with previous disclosures[27] Assets and Liabilities - The company's total assets increased by 15.78% to CNY 767,024,991.09 compared to CNY 662,506,745.80 in the previous year[52] - The company has maintained a stable debt ratio, with a consolidated asset-liability ratio of 32.34% in 2024, slightly up from 31.30% in 2023[25] - The company's financial structure shows a significant increase in cash and cash equivalents, rising by 255.01% from 94,460,172.62 yuan (14.26% of total assets) to 335,345,589.23 yuan (43.72% of total assets) by the end of 2024[51] - The company has a total of 90,331,782.00 CNY in restricted cash, representing 11.78% of total assets, primarily for bank acceptance bill guarantees[133] Production and Capacity - The company achieved a total production capacity of 270,000 tons/year for nitric acid after successfully launching a 135,000 tons/year nitric acid project in January 2024, enhancing production scale and cost control capabilities[41] - The company has an annual production capacity of 270,000 tons of nitric acid, making it one of the major suppliers in China[171] - The production capacity for potassium nitrate and water-soluble fertilizer is 100,000 tons/year, achieving a utilization rate of 104.00%[180] - The magnesium nitrate and calcium magnesium fertilizer production capacity is 100,000 tons/year, with a utilization rate of 57.66%[180] - The company plans to complete a 200,000 tons/year sodium nitrate production facility by June 2025, with a total investment of approximately 153.53 million yuan[180] Research and Development - Research and development expenses surged by 159.04%, reflecting the company's commitment to enhancing its R&D capabilities[67] - The company is focusing on the development of molten salt energy storage materials and innovative high-efficiency nitrate water-soluble fertilizers as long-term goals[36] - The total number of patents owned by the company increased to 23 from 20 in the previous period[98] - The company has established a complete independent intellectual property technology system for downstream products such as potassium nitrate and magnesium nitrate, with a production capacity of 200,000 tons for high-purity potassium nitrate[171] - The company plans to enhance its R&D capabilities by increasing investment in technology and establishing a comprehensive R&D system, while also focusing on intellectual property protection and patent applications[119] Market and Sales - The revenue from potassium nitrate increased by 7.30% year-on-year, contributing significantly to the overall revenue growth, with sales volume up by 17.17%[78] - Domestic revenue was ¥617,873,058.65, with a 4.16% increase compared to the previous year, while overseas revenue decreased by 2.39% to ¥164,584,189.24[77] - The company's main business revenue for 2024 reached ¥779,060,608.46, representing a 3.10% increase compared to ¥755,629,981.00 in 2023[73] - The company's major customers accounted for 36.37% of total sales, with the largest customer contributing ¥85,241,103.43, or 10.89% of total sales[82] Environmental and Safety - The company has committed to environmental protection measures, investing in advanced pollution treatment facilities[124] - The company has established 27 environmental protection systems and 92 safety production systems to ensure compliance with safety and environmental regulations[187] - The company's environmental investment during the reporting period amounted to 6.0147 million yuan, accounting for 0.77% of operating revenue[186] - There were no major safety production accidents or significant environmental violations reported during the period[188] Governance and Management - The company has a governance structure that includes a general meeting of shareholders, a board of directors, independent directors, a supervisory board, and senior management, ensuring clear responsibilities and coordination[192] - The board of directors consists of 9 members, while the supervisory board has 3 members and there are 5 senior management personnel[154] - The company has implemented a decision-making mechanism for major issues, adhering to relevant procedures and regulations without any violations reported[199] - The company has not modified its articles of association during the reporting period[200] Employee and Talent Management - The total number of employees increased to 342, up by 24 employees year-on-year[161] - The company has developed a structured recruitment plan to meet staffing needs and ensure talent reserves[162] - The company has established a comprehensive training system to enhance employee skills and promote internal talent development[162] - The company implemented a competitive salary policy to attract and retain talent, linking compensation to performance evaluations[161] Risks and Challenges - The company faces risks related to price volatility of raw materials such as liquid ammonia and potassium chloride, which could impact profitability if not managed effectively[121] - The company will adjust production and sales volumes based on market conditions to mitigate risks related to product price fluctuations[123] - The company has developed comprehensive emergency response plans to address safety risks associated with its operations involving hazardous materials[123]
迪尔化工换手率35.22%,龙虎榜上榜营业部合计净买入1625.53万元
Zheng Quan Shi Bao Wang· 2025-03-28 12:13
证券时报·数据宝统计显示,上榜的前五大买卖营业部合计成交7969.47万元,其中,买入成交额为 4797.50万元,卖出成交额为3171.97万元,合计净买入1625.53万元。 具体来看,今日上榜营业部中,第一大买入营业部为海通证券股份有限公司长沙五一大道营业部,买入 金额为1324.38万元,第一大卖出营业部为国金证券股份有限公司上海静安区南京西路证券营业部,卖 出金额为737.09万元。 迪尔化工(831304)今日下跌15.68%,全天换手率35.22%,成交额4.59亿元,振幅13.46%。龙虎榜数据 显示,营业部席位合计净买入1625.53万元。 北交所公开信息显示,当日该股因日换手率达35.22%上榜,营业部席位合计净买入1625.53万元。 近半年该股累计上榜龙虎榜5次,上榜次日股价平均跌6.93%,上榜后5日平均跌16.29%。(数据宝) 迪尔化工3月28日交易公开信息 | 买/ | 会员营业部名称 | 买入金额(万 | 卖出金额(万 | | --- | --- | --- | --- | | 卖 | | 元) | 元) | | 买一 | 海通证券股份有限公司长沙五一大道营业部 | 1324 ...
206股获杠杆资金大手笔加仓
Zheng Quan Shi Bao Wang· 2025-03-28 01:57
Market Overview - On March 27, the Shanghai Composite Index rose by 0.15%, with the total margin financing balance in the market at 1,926.55 billion yuan, a decrease of 3.164 billion yuan from the previous trading day [1] - The margin financing balance in the Shanghai Stock Exchange was 976.08 billion yuan, down by 1.008 billion yuan; in the Shenzhen Stock Exchange, it was 944.93 billion yuan, down by 2.182 billion yuan; and in the Beijing Stock Exchange, it was 5.543 billion yuan, up by 0.027 billion yuan [1] Industry Analysis - Among the industries classified by Shenwan, 12 industries saw an increase in financing balance, with the public utilities sector leading with an increase of 0.305 billion yuan, followed by household appliances and coal industries with increases of 0.194 billion yuan and 0.117 billion yuan, respectively [1] Individual Stock Performance - A total of 1,580 stocks experienced an increase in financing balance, accounting for 42.97% of the total, with 206 stocks showing an increase of over 5% [1] - The stock with the largest increase in financing balance was Deer Chemical, with a latest financing balance of 22.4955 million yuan, reflecting a 99.74% increase from the previous trading day, and its stock price rose by 3.06% [1] - Other notable stocks with significant increases in financing balance included Haisheng Pharmaceutical and Duorui Pharmaceutical, with increases of 75.11% and 70.60%, respectively [1] Top Gainers and Losers - Among the top 20 stocks with the largest increase in financing balance, the average increase in stock price was 2.22%, with notable gainers including Sanwei Co., Chip Microelectronics, and Haisheng Pharmaceutical, which rose by 29.96%, 12.29%, and 9.67%, respectively [2] - Conversely, the top losers included Qiuguan Cable, Baofeng Energy, and Renxin New Materials, which fell by 10.10%, 9.99%, and 4.78%, respectively [2] Margin Financing Decrease - There were 2,097 stocks that saw a decrease in financing balance, with 225 stocks experiencing a decline of over 5% [4] - The stock with the largest decrease in financing balance was Tiangang Co., with a latest financing balance of 4.0218 million yuan, down by 39.81% from the previous trading day [5] - Other stocks with significant decreases included Dayu Biological and Zhonggu Logistics, with declines of 36.89% and 35.13%, respectively [5]
迪尔化工龙虎榜:营业部净买入363.11万元
Zheng Quan Shi Bao Wang· 2025-03-26 14:48
证券时报•数据宝统计显示,上榜的前五大买卖营业部合计成交1.11亿元,其中,买入成交额为5753.27万元,卖出成交额为5390.16万元,合计净 买入363.11万元。 具体来看,今日上榜营业部中,第一大买入营业部为国信证券股份有限公司深圳红岭中路证券营业部,买入金额为1329.98万元,第一大卖出营业 部为长城证券股份有限公司西安锦业路营业部,卖出金额为902.23万元。(数据宝) 迪尔化工3月26日交易公开信息 迪尔化工龙虎榜:营业部净买入363.11万元 (原标题:迪尔化工龙虎榜:营业部净买入363.11万元) 迪尔化工(831304)今日下跌1.43%,全天换手率35.04%,成交额4.82亿元,振幅11.18%。龙虎榜数据显示,营业部席位合计净买入363.11万元。 北交所公开信息显示,当日该股因日换手率达35.04%上榜,营业部席位合计净买入363.11万元。 (产品代码: 560800) ★ 跟踪:中证数字经济主题指数 近五日涨跌:-5.50% 市盈率: 65.30倍 资金流向:最新份额为9.4亿份,增加了200.0万份,主力资金净 流出78.7万元。 估值分位: 90.28% | 买/卖 | ...
迪尔化工振幅32.59%,龙虎榜上榜营业部合计净卖出250.60万元
Zheng Quan Shi Bao Wang· 2025-03-25 12:40
迪尔化工3月25日交易公开信息 | 买/卖 | 会员营业部名称 | 买入金额(万元) | 卖出金额(万元) | | --- | --- | --- | --- | | 买一 | 申万宏源证券有限公司济南历山路证券营业部 | 2194.79 | 0.00 | | 买二 | 国泰君安证券股份有限公司广东东莞体育路营业部 | 909.85 | 10.26 | | 买三 | 长城证券股份有限公司西安锦业路营业部 | 889.89 | 0.00 | | 买四 | 平安证券股份有限公司上海分公司 | 858.68 | 99.81 | | 买五 | 华鑫证券有限责任公司绍兴胜利东路营业部 | 799.88 | 0.00 | | 卖一 | 中国银河证券股份有限公司南京上海路证券营业部 | 0.39 | 3789.25 | | 卖二 | 国信证券股份有限公司深圳红岭中路证券营业部 | 452.05 | 793.79 | | 卖三 | 国信证券股份有限公司广州珠江东路证券营业部 | 76.80 | 678.84 | 迪尔化工振幅32.59%,龙虎榜上榜营业部合计净卖 出250.60万元 迪尔化工(831304)今日上涨27.61 ...
迪尔化工(831304) - 关于年产5万吨硝酸钾装置开展“三化”改造的公告
2025-03-17 09:00
证券代码:831304 证券简称:迪尔化工 公告编号:2025-002 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 为提高生产效率、减少能源消耗、提升产品质量,公司决定对年产5万吨的 硝酸钾装置实施"三化"(机械化、自动化、智能化)升级。公司已于2025年3 月13日获得"三化"改造项目的《建筑工程施工许可证》,并计划在2025年6月 30日前完成改造工作。此次改造预计不会改变装置的产能。 尽管本次改造可能会短期内影响硝酸钾的产量和销量,但长远来看,它将 有助于全面提升装置的生产效率、产品质量和安全水平,符合公司的经营发展 和战略规划。公司已根据市场状况妥善安排了生产和库存,预计此次"三化" 改造不会对公司的生产经营活动造成重大不利影响。 公司将持续关注本次改造的进展,并按照相关法规及时履行信息披露义务。 请广大投资者注意投资风险。 特此公告。 山东华阳迪尔化工股份有限公司 董事会 2025 年 3 月 17 日 ...
迪尔化工(831304) - 2024 Q4 - 年度业绩
2025-02-25 14:10
Financial Performance - The company's operating revenue for 2024 reached ¥782,457,247.89, representing a year-on-year increase of 2.71%[6] - The total profit amounted to ¥113,403,132.27, reflecting a growth of 7.71% compared to the previous year[6] - Net profit attributable to shareholders was ¥86,154,377.73, up 9.31% year-on-year[6] - The net profit excluding non-recurring gains and losses increased by 26.95% to ¥84,599,302.57[7] - Basic earnings per share rose to ¥0.53, marking a 1.92% increase from the previous year[6] Assets and Equity - Total assets at the end of the reporting period were ¥766,969,053.09, a 15.77% increase year-on-year[5] - Shareholders' equity attributable to the company reached ¥504,310,481.57, up 10.80% from the beginning of the period[5] Production and Cost Efficiency - The company achieved self-sufficiency in the production of dilute nitric acid and steam after the commissioning of a new 135,000-ton nitric acid facility, which helped reduce production costs[6] - The comprehensive gross profit margin improved due to the use of self-produced raw materials, contributing to the increase in net profit[7] Strategic Focus - The company emphasizes the importance of its long-term strategy to build a complete industrial chain of "nitric acid-nitrate-molten salt" to enhance market competitiveness[6]
迪尔化工:2024年第二次临时股东会决议公告
2024-12-30 08:08
证券代码:831304 证券简称:迪尔化工 公告编号:2024-079 山东华阳迪尔化工股份有限公司 2024 年第二次临时股东会决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 (一)会议召开情况 1.会议召开时间:2024 年 12 月 27 日 2.会议召开地点:泰安市宁阳县经济开发区葛石路 06 号迪尔化工会议室 3.会议召开方式:现场投票和网络投票相结合的方式 4.会议召集人:董事会 (三)公司董事、监事、高级管理人员出席或列席股东会情况 1.公司在任董事 9 人,出席 9 人; 2.公司在任监事 3 人,出席 3 人; 3.公司董事会秘书出席会议; 4.公司高级管理人员、见证律师列席会议。 5.会议主持人:董事长孙立辉先生 6.召开情况合法、合规、合章程性说明: 本次股东会的召集程序符合《公司法》等相关法律、法规、规范性文件和《公 司章程》《股东会议事规则》的规定,无需其他相关部门批准或履行其他程序。 (二)会议出席情况 出席和授权出席本次股东会的股东共 28 ...